[Cardiovascular safety of new type 2 diabetes drugs]. | Semergen;40(2): 55-6, 2014 Mar. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

[Cardiovascular safety of new type 2 diabetes drugs]. / Seguridad cardiovascular de los nuevos fármacos para la diabetes tipo 2.

Hormigo Pozo, A; Mancera Romero, J.

Affiliation

Hormigo Pozo A; Grupo de Trabajo Diabetes Semergen.
Mancera Romero J; Grupo de Trabajo Diabetes Semergen. Electronic address: jmancerar@semergen.es.

Semergen ; 40(2): 55-6, 2014 Mar.

Article in Es | MEDLINE | ID: mdl-24655909

Subject(s)

Cardiovascular Diseases/chemically induced; Diabetes Mellitus, Type 2/drug therapy; Hypoglycemic Agents/adverse effects; Humans; Hypoglycemic Agents/therapeutic use

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Diabetes Mellitus, Type 2 / Hypoglycemic Agents Limits: Humans Language: Es Journal: Semergen Year: 2014 Document type: Article Country of publication: Spain

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Diabetes Mellitus, Type 2 / Hypoglycemic Agents Limits: Humans Language: Es Journal: Semergen Year: 2014 Document type: Article Country of publication: Spain